Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KAUFMAN, D. W.
Right arrow Articles by SHAPIRO, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAUFMAN, D. W.
Right arrow Articles by SHAPIRO, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 131, No. 3: 483-490
Copyright © 1990 by The Johns Hopkins University School of Hygiene and Public Health

research-article

DIAZEPAM USE IN RELATION TO BREAST CANCER: RESULTS FROM TWO CASE-CONTROL STUDIES

DAVID W. KAUFMAN1,, MARTHA M. WERLER1, JULIE R. PALMER1, LYNN ROSENBERG1, PAUL D. STOLLEY2, M. ELLEN WARSHAUER3, E. AILEEN CLARKE4, DONALD R. MILLER1 and SAMUEL SHAPIRO1

1Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine Brookline, MA
2Department of Medicine, Section of General Medicine, Clinical Epidemiology Unit, The University of Pennsylvania School of Medicine Philadelphia, PA
3Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center New York, NY
4Division of Epidemiology and Statistics, Ontario Cancer Treatment and Research Foundation 7 Overlea Boulevard, Toronto, Ontario M4H 1A8, Canada

Reprint requests to Dr. David W. Kaufman, Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine, 1371 Beacon St., Brookline, MA 02146

The relation between diazepam use and breast cancer was explored in two case-control studies. The first (1981–1987) was a hospital-based study in the United States of 3,078 cases of breast cancer, 1,259 controls with other malignancies, and 672 controls with nonmalignant conditions. The relative risk estimates for regular diazepam use (at least 4 days per week for at least 6 months) that antedated the diagnosis of breast cancer by at least 12 months were 1.0 (95% confidence interval (Cl) 0.6–1.7) using the cancer controls and 0.8 (95% Cl 0.4–1.8) using the noncancer controls. Risk factors for breast cancer were taken into account in the estimates. There was no association for regular use lasting at least 5 years or for regular use that took place exclusively in the recent or more distant past. The second study (1982–1986), conducted in Toronto, Ontario, Canada, was community-based, and included 607 cases of breast cancer and 1,214 neighbor controls selected from municipal voting and census records. After control of confounding, the relative risk estimate for regular diazepam use was 0.8 (95% Cl 0.5–1.3). Again, there was no association for long-term, past, or recent regular use. The results of both studies suggest that regular diazepam use does not increase the risk of breast cancer. The findings are strengthened by the similarity of the results using three different control groups—women with cancer, women with nonmalignant conditions, and neighbors.

breast neoplasms; diazepam


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.